¡If B cells affected, intravenous immunonglobulins are given every 3-4 weeks
¡Gene therapy when a matched transplant is not available. Mainly with ADA-SCID, more recently **γ**c chain cytokine receptor gene.
¡Haemopoietic stem cell transplant (bone marrow, peripheral blood, cord blood) is treatment of choice, if a suitable match is available
¡Patients with adenosine deaminase deficiency, ADA SCID, without a suitable HSCT match, receive weekly ADA enzyme replacement therapy